They are proposing (AGM resolution) to issue 90M shares ..this has been announced so would not be the reason for the Trading Halt as it still requires shareholder approval at the AGM
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%